Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 11/20 | 0.77 |
| ▸ | NPSR1 | Q6W5P4 | 9/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.77 |
| ▸ | MITF | O75030 | 6/20 | 0.77 |
| ▸ | HTT | P42858 | 6/20 | 0.77 |
| ▸ | MEN1 | O00255 | 6/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.77 |
| ▸ | LMNA | P02545 | 5/20 | 0.77 |
| ▸ | TP53 | P04637 | 2/20 | 0.77 |
| ▸ | NPC1 | O15118 | 2/20 | 0.77 |
| ▸ | RAB9A | P51151 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 7/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.60 |
| ▸ | XBP1 | P17861 | 3/20 | 0.60 |
| ▸ | APAF1 | O14727 | 1/20 | 0.60 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | IDE | P14735 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26812164 | 1.00 | MAPK1 (0.77) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18969198 | 1.00 | MAPK1 (0.77) | MAPK1NPSR1KMT2AMITFHTT | |
| Iodide SCHEMBL29603380 | 0.99 | MAPK1 (0.76) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18968682 | 0.91 | MAPK1 (0.81) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18969932 | 0.90 | MAPK1 (0.81) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18968617 | 0.90 | MAPK1 (0.81) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18968683 | 0.89 | MAPK1 (0.83) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18969964 | 0.89 | MAPK1 (0.83) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL26812174 | 0.89 | MAPK1 (0.82) | MAPK1NPSR1KMT2AMITFHTT | |
| SCHEMBL18968670 | 0.88 | MAPK1 (0.98) | MAPK1NPSR1KMT2AMITFHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355647-A1 | Marker for determining anti-cancer effects of mitochondrial oxidative phosphorylation pathway inhibitor | NANJING SHIJIANG MEDICINE TECHNOLOGY CO., LTD (CN) | 2023-11-09 | — | — | US | disclosed |
| WO-2017100525-A1 | SUBSTITUTED BENZIMIDAZOLIUM, PYRIDO-IMIDAZOLIUM, OR PYRAZINO-IMIDAZOLIUM COMPOUNDS AS CHEMOTHERAPEUTICS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355647-A1 | Marker for determining anti-cancer effects of mitochondrial oxidative phosphorylation pathway inhibitor | SHMT2, UHRF1, SHMT1 | MAPK1 533/4885NPSR1 4308/4885KMT2A 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.